CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop vaccines and diagnostic tests for orbiviruses affecting livestock, focusing on Bluetongue Virus, African Horse Sickness Virus, and Epizootic Haemorrhagic Disease Virus. It seeks to create multivalent vaccines and high-throughput diagnostic assays to enhance immune response and differentiate…
The major outstanding challenges of orbivirus vaccine research is to develop vaccines that can afford a broad protective immune response against as many serotypes of each virus as possible, and to develop a high throughput DIVA assay (e.g. an ELISA).
This project will use a coordinated multipartner approach to address these issues, to develop new experimental prototype vaccines and diagnostic approaches.
It will build on specific expertise and reagents that are only available within the consorti…
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Madrid
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE
France, Lyon
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
